Project 3 Example: Human-AI Collaboration Tester (HAICT) Exp. 7
Launched by BRIGHAM AND WOMEN'S HOSPITAL · Feb 28, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, called the Human-AI Collaboration Tester (HAICT) Exp. 7, is exploring how the use of artificial intelligence (AI) can help humans make better decisions when it comes to diagnosing medical conditions. Specifically, the study looks at how changes in the way AI presents information can impact how well people, like doctors or radiologists, perform in tasks such as deciding whether a patient should undergo further examination after a mammogram. The goal is to understand how AI can serve as a helpful tool in improving decision-making in healthcare.
The trial is currently recruiting participants aged 65 to 74, and it is open to all genders. To join, individuals must pass a color vision test called the Ishihara test and have vision that is corrected to 20/25 or better. If you participate, you'll be involved in an experiment where you help researchers understand the effects of AI on decision-making. This research could lead to better diagnostic tools and ultimately improve patient care.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • - All welcome to enroll on line
- Exclusion Criteria:
- • Must pass the Ishihara color vision screening test
- • 20/25 vision (with correction)
About Brigham And Women's Hospital
Brigham and Women's Hospital (BWH) is a leading academic medical center located in Boston, Massachusetts, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As an integral part of the Partners HealthCare system, BWH combines cutting-edge medical education with a focus on patient-centered care, fostering an environment that promotes groundbreaking clinical trials across various specialties. The hospital is dedicated to translating scientific discoveries into effective treatments, making significant contributions to the fields of cardiovascular medicine, oncology, and women's health, among others. With a robust infrastructure for research and a collaborative approach, BWH aims to improve patient outcomes and enhance the overall quality of healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Boston, Massachusetts, United States
Patients applied
Trial Officials
Jeremy M Wolfe, PhD
Principal Investigator
Brigham and Women's Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials